Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
WAT
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
-3.25%
$241.87-8.13Delayed quote: Sep 15, 2026, 2:30 PM EDT
Market Cap
$32.36B
52W Range
$197.81 - $495.55
WAT
Waters Corporation
+2.63%
$420.79+10.78Delayed quote: Sep 15, 2026, 2:25 PM EDT
Market Cap
$31.47B
52W Range
$282.77 - $426.22
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 40.86 | 104.94 |
| Forward P/E | 36.24 | 28.87 |
| P/B Ratio | 23.90 | 2.07 |
| P/S Ratio | 6.74 | 6.78 |
| P/FCF Ratio | 59.65 | 78.98 |
| EV/EBITDA | 30.28 | 39.00 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 50.8% |
| Operating Margin | 20.8% | 28.2% |
| Net Margin | 16.8% | 3.6% |
| ROE | 59.7% | 1.1% |
| ROA | 14.5% | 0.7% |
| ROIC | 24.7% | 1.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 1.86 |
| Quick Ratio | 2.99 | 1.29 |
| Debt/Equity | 0.94 | 0.35 |
| Interest Coverage | 1.99 | 12.84 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.